Monday, November 20, 2017 1:30:20 PM
Quote from David Mersky email 11/20/17:
Hi —————————,
As you know, I can't comment on certain information, and I'm aware there hasn't been any recent disclosures from NOHO. As you may have noted from the interview, the interest in moving forward with the NOHO brands remains a core element of our operations. The company has no interest in making announcements for the sole purpose of maintaining market interest, although I can assure you that the DRNK shareholder is and will continue to be my highest of priorities. As you may have surmised, a lot of action is taking place and we look forward to updating the public as appropriate. Thanks again for your continued support and please let me know if I can be of any further assistance to you.
David Mersky
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM